 Lisa Cicutto
Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| School Health Services | 16 | 2024 | 232 | 5.260 |
Why?
| | Asthma | 56 | 2024 | 2213 | 4.920 |
Why?
| | School Nursing | 3 | 2018 | 30 | 1.590 |
Why?
| | Patient Education as Topic | 14 | 2015 | 734 | 1.180 |
Why?
| | Needs Assessment | 4 | 2024 | 356 | 1.040 |
Why?
| | Ontario | 20 | 2011 | 90 | 0.970 |
Why?
| | Disease Management | 6 | 2018 | 584 | 0.900 |
Why?
| | Nurses, Public Health | 2 | 2014 | 5 | 0.900 |
Why?
| | Evidence-Based Practice | 3 | 2016 | 208 | 0.870 |
Why?
| | Community Health Services | 5 | 2018 | 227 | 0.800 |
Why?
| | Program Development | 5 | 2018 | 357 | 0.740 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 5 | 2018 | 953 | 0.710 |
Why?
| | Social Determinants of Health | 1 | 2024 | 221 | 0.700 |
Why?
| | Schools | 9 | 2022 | 436 | 0.620 |
Why?
| | Colorado | 9 | 2024 | 4399 | 0.590 |
Why?
| | Child | 33 | 2024 | 20805 | 0.590 |
Why?
| | Self Care | 6 | 2016 | 369 | 0.580 |
Why?
| | Particulate Matter | 1 | 2018 | 245 | 0.510 |
Why?
| | Competency-Based Education | 1 | 2016 | 68 | 0.510 |
Why?
| | Frailty | 1 | 2018 | 153 | 0.490 |
Why?
| | Respiratory Therapy | 1 | 2015 | 23 | 0.480 |
Why?
| | Nurse's Role | 1 | 2016 | 139 | 0.480 |
Why?
| | Primary Health Care | 6 | 2014 | 1641 | 0.460 |
Why?
| | Ambulatory Care | 1 | 2018 | 504 | 0.450 |
Why?
| | Attitude to Health | 4 | 2007 | 431 | 0.440 |
Why?
| | Practice Guidelines as Topic | 7 | 2016 | 1490 | 0.440 |
Why?
| | Humans | 74 | 2024 | 128495 | 0.430 |
Why?
| | Health Personnel | 3 | 2016 | 649 | 0.420 |
Why?
| | Anaphylaxis | 2 | 2011 | 98 | 0.420 |
Why?
| | Rural Health Services | 1 | 2014 | 110 | 0.410 |
Why?
| | Emergency Service, Hospital | 5 | 2018 | 1900 | 0.400 |
Why?
| | Medical Records | 4 | 2009 | 170 | 0.380 |
Why?
| | Health Services Accessibility | 5 | 2024 | 901 | 0.370 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 316 | 0.370 |
Why?
| | Hospitalization | 3 | 2018 | 2069 | 0.350 |
Why?
| | Occupational Diseases | 1 | 2011 | 138 | 0.330 |
Why?
| | Adolescent | 20 | 2024 | 20304 | 0.320 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2015 | 1276 | 0.320 |
Why?
| | Child Care | 1 | 2009 | 26 | 0.320 |
Why?
| | Female | 38 | 2024 | 68266 | 0.310 |
Why?
| | Bronchodilator Agents | 5 | 2021 | 243 | 0.310 |
Why?
| | Cost of Illness | 2 | 2008 | 278 | 0.300 |
Why?
| | Population Surveillance | 1 | 2011 | 435 | 0.300 |
Why?
| | Plagiarism | 1 | 2008 | 3 | 0.300 |
Why?
| | Male | 36 | 2024 | 63043 | 0.290 |
Why?
| | Child, Preschool | 13 | 2024 | 10487 | 0.290 |
Why?
| | Hotlines | 1 | 2007 | 32 | 0.290 |
Why?
| | Observer Variation | 1 | 2008 | 313 | 0.280 |
Why?
| | Disease Progression | 3 | 2018 | 2604 | 0.270 |
Why?
| | Public Health Nursing | 1 | 2006 | 5 | 0.270 |
Why?
| | Education, Medical, Continuing | 2 | 2005 | 121 | 0.260 |
Why?
| | Documentation | 1 | 2008 | 183 | 0.260 |
Why?
| | Anti-Asthmatic Agents | 7 | 2009 | 371 | 0.250 |
Why?
| | Public Health Practice | 1 | 2006 | 64 | 0.250 |
Why?
| | Program Evaluation | 4 | 2018 | 872 | 0.250 |
Why?
| | Education, Professional | 1 | 2005 | 18 | 0.250 |
Why?
| | Guidelines as Topic | 2 | 2021 | 260 | 0.240 |
Why?
| | Lung Transplantation | 2 | 2007 | 278 | 0.240 |
Why?
| | Certification | 1 | 2005 | 94 | 0.230 |
Why?
| | Health Care Costs | 1 | 2008 | 366 | 0.230 |
Why?
| | Adult | 27 | 2018 | 35299 | 0.230 |
Why?
| | Recurrence | 1 | 2007 | 1004 | 0.230 |
Why?
| | Clinical Competence | 2 | 2016 | 1009 | 0.230 |
Why?
| | Specialization | 1 | 2005 | 144 | 0.230 |
Why?
| | Pilot Projects | 3 | 2024 | 1568 | 0.220 |
Why?
| | Respiratory Sounds | 1 | 2024 | 120 | 0.220 |
Why?
| | Registries | 1 | 2011 | 1883 | 0.210 |
Why?
| | Breath Tests | 1 | 2004 | 89 | 0.210 |
Why?
| | Quality of Life | 5 | 2013 | 2688 | 0.210 |
Why?
| | Vulnerable Populations | 1 | 2024 | 157 | 0.210 |
Why?
| | Biomedical Research | 2 | 2023 | 633 | 0.210 |
Why?
| | Delphi Technique | 1 | 2024 | 222 | 0.200 |
Why?
| | Depression | 1 | 2011 | 1292 | 0.200 |
Why?
| | Awards and Prizes | 1 | 2023 | 60 | 0.200 |
Why?
| | Employment | 1 | 2004 | 167 | 0.200 |
Why?
| | Nebulizers and Vaporizers | 2 | 2015 | 81 | 0.200 |
Why?
| | Social Support | 4 | 2011 | 589 | 0.190 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 88 | 0.190 |
Why?
| | Organizational Case Studies | 2 | 2016 | 74 | 0.190 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 1090 | 0.190 |
Why?
| | Sputum | 1 | 2004 | 301 | 0.190 |
Why?
| | Monitoring, Physiologic | 1 | 2004 | 264 | 0.190 |
Why?
| | Parents | 3 | 2024 | 1307 | 0.190 |
Why?
| | Surveys and Questionnaires | 11 | 2015 | 5371 | 0.180 |
Why?
| | Albuterol | 1 | 2021 | 103 | 0.180 |
Why?
| | Health Services | 3 | 2013 | 97 | 0.180 |
Why?
| | Adaptation, Psychological | 2 | 2010 | 617 | 0.180 |
Why?
| | Bronchial Neoplasms | 1 | 2000 | 14 | 0.180 |
Why?
| | Health Equity | 1 | 2022 | 82 | 0.170 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2000 | 17 | 0.170 |
Why?
| | Lung Diseases | 2 | 2022 | 715 | 0.170 |
Why?
| | Societies, Medical | 1 | 2024 | 744 | 0.170 |
Why?
| | Family | 3 | 2018 | 649 | 0.170 |
Why?
| | Middle Aged | 15 | 2018 | 30921 | 0.160 |
Why?
| | Absenteeism | 3 | 2018 | 47 | 0.160 |
Why?
| | Connecticut | 1 | 2018 | 26 | 0.150 |
Why?
| | Population | 1 | 2018 | 33 | 0.150 |
Why?
| | Case Management | 1 | 2018 | 63 | 0.150 |
Why?
| | Health Policy | 1 | 2021 | 351 | 0.150 |
Why?
| | Qualitative Research | 2 | 2024 | 1227 | 0.150 |
Why?
| | Hypersensitivity | 2 | 2011 | 249 | 0.150 |
Why?
| | Students | 2 | 2014 | 570 | 0.140 |
Why?
| | Practice Patterns, Physicians' | 4 | 2000 | 1262 | 0.140 |
Why?
| | Health Services Needs and Demand | 2 | 2011 | 262 | 0.140 |
Why?
| | Occupational Exposure | 2 | 2011 | 299 | 0.140 |
Why?
| | Aged | 11 | 2018 | 21974 | 0.140 |
Why?
| | Nursing Education Research | 1 | 2016 | 33 | 0.130 |
Why?
| | Pulmonary Medicine | 3 | 2024 | 78 | 0.130 |
Why?
| | Mass Screening | 1 | 2024 | 1146 | 0.130 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 456 | 0.130 |
Why?
| | Biomarkers | 2 | 2024 | 3893 | 0.130 |
Why?
| | Research Personnel | 2 | 2015 | 156 | 0.120 |
Why?
| | Patient Participation | 1 | 1999 | 409 | 0.120 |
Why?
| | Education, Graduate | 1 | 2015 | 35 | 0.120 |
Why?
| | Urban Population | 1 | 2018 | 441 | 0.120 |
Why?
| | Information Dissemination | 2 | 2015 | 204 | 0.120 |
Why?
| | Health Education | 2 | 2009 | 332 | 0.120 |
Why?
| | Rural Population | 1 | 2018 | 517 | 0.110 |
Why?
| | Interviews as Topic | 3 | 2024 | 715 | 0.110 |
Why?
| | Epinephrine | 2 | 2011 | 140 | 0.110 |
Why?
| | Administration, Inhalation | 2 | 2015 | 661 | 0.110 |
Why?
| | Education, Continuing | 1 | 2014 | 39 | 0.110 |
Why?
| | Hypertension | 1 | 2022 | 1236 | 0.100 |
Why?
| | Diabetes Complications | 1 | 2015 | 223 | 0.100 |
Why?
| | Drug Utilization | 1 | 2013 | 169 | 0.100 |
Why?
| | Universities | 1 | 2015 | 399 | 0.100 |
Why?
| | Mentors | 3 | 2023 | 178 | 0.100 |
Why?
| | Health Services Research | 1 | 2015 | 389 | 0.100 |
Why?
| | Severity of Illness Index | 4 | 2008 | 2719 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2018 | 579 | 0.100 |
Why?
| | Activities of Daily Living | 2 | 2006 | 383 | 0.100 |
Why?
| | General Surgery | 1 | 2013 | 152 | 0.100 |
Why?
| | Motivation | 3 | 2007 | 545 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1212 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 258 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2024 | 580 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 296 | 0.090 |
Why?
| | Infant | 5 | 2024 | 9001 | 0.090 |
Why?
| | Risk Factors | 5 | 2023 | 9737 | 0.090 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 272 | 0.090 |
Why?
| | Internet | 2 | 2011 | 613 | 0.080 |
Why?
| | Medication Adherence | 1 | 2015 | 558 | 0.080 |
Why?
| | Health Promotion | 1 | 2016 | 716 | 0.080 |
Why?
| | Health Services Administration | 1 | 2009 | 8 | 0.080 |
Why?
| | Young Adult | 2 | 2018 | 12349 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2008 | 3021 | 0.080 |
Why?
| | Suction | 1 | 2009 | 32 | 0.080 |
Why?
| | Curriculum | 3 | 2015 | 910 | 0.080 |
Why?
| | Nursing Methodology Research | 2 | 2007 | 46 | 0.080 |
Why?
| | Age Factors | 2 | 2007 | 3122 | 0.080 |
Why?
| | Demography | 1 | 2009 | 278 | 0.070 |
Why?
| | Canada | 5 | 2011 | 346 | 0.070 |
Why?
| | Delivery of Health Care | 2 | 2022 | 889 | 0.070 |
Why?
| | Scientific Misconduct | 1 | 2008 | 12 | 0.070 |
Why?
| | Quality Control | 1 | 2008 | 157 | 0.070 |
Why?
| | Databases as Topic | 1 | 2007 | 59 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2009 | 5045 | 0.070 |
Why?
| | Risk | 1 | 2010 | 853 | 0.070 |
Why?
| | Circadian Rhythm | 5 | 1992 | 412 | 0.070 |
Why?
| | Food Hypersensitivity | 1 | 2010 | 173 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2011 | 863 | 0.070 |
Why?
| | Information Services | 1 | 2007 | 46 | 0.070 |
Why?
| | Health Status Indicators | 1 | 2007 | 167 | 0.070 |
Why?
| | Informed Consent | 1 | 2007 | 168 | 0.060 |
Why?
| | Employee Performance Appraisal | 1 | 2005 | 7 | 0.060 |
Why?
| | Child Welfare | 1 | 2007 | 211 | 0.060 |
Why?
| | Family Practice | 2 | 2000 | 434 | 0.060 |
Why?
| | Seasons | 1 | 2008 | 498 | 0.060 |
Why?
| | Health Plan Implementation | 1 | 2006 | 137 | 0.060 |
Why?
| | Telephone | 1 | 2005 | 166 | 0.060 |
Why?
| | Decision Making | 2 | 2011 | 847 | 0.060 |
Why?
| | Patient Admission | 1 | 2006 | 182 | 0.060 |
Why?
| | Counseling | 1 | 2007 | 384 | 0.060 |
Why?
| | Leukotriene Antagonists | 1 | 2004 | 43 | 0.050 |
Why?
| | Internship and Residency | 1 | 2013 | 1045 | 0.050 |
Why?
| | Health Surveys | 1 | 2006 | 493 | 0.050 |
Why?
| | Europe | 1 | 2024 | 360 | 0.050 |
Why?
| | Patient Care Team | 1 | 2008 | 598 | 0.050 |
Why?
| | Financing, Organized | 1 | 2023 | 30 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 2004 | 130 | 0.050 |
Why?
| | Atherectomy | 1 | 2023 | 36 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 214 | 0.050 |
Why?
| | Vascular Patency | 1 | 2023 | 102 | 0.050 |
Why?
| | United States | 4 | 2023 | 13840 | 0.050 |
Why?
| | Popliteal Artery | 1 | 2023 | 58 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2005 | 256 | 0.050 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 56 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 122 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2023 | 10162 | 0.050 |
Why?
| | Theophylline | 4 | 1992 | 64 | 0.050 |
Why?
| | Faculty | 1 | 2023 | 135 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 513 | 0.050 |
Why?
| | Focus Groups | 1 | 2004 | 452 | 0.050 |
Why?
| | Femoral Artery | 1 | 2023 | 170 | 0.050 |
Why?
| | Chronic Disease | 1 | 2007 | 1692 | 0.050 |
Why?
| | Educational Status | 1 | 2004 | 470 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2864 | 0.050 |
Why?
| | Risk Assessment | 2 | 2007 | 3232 | 0.050 |
Why?
| | Spirometry | 2 | 2000 | 254 | 0.050 |
Why?
| | Guideline Adherence | 2 | 2008 | 524 | 0.050 |
Why?
| | Self Efficacy | 1 | 2004 | 371 | 0.040 |
Why?
| | Physicians | 1 | 2009 | 863 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2004 | 470 | 0.040 |
Why?
| | Patient Compliance | 1 | 2004 | 560 | 0.040 |
Why?
| | Peer Group | 2 | 2011 | 225 | 0.040 |
Why?
| | Cooperative Behavior | 2 | 2015 | 424 | 0.040 |
Why?
| | Time Factors | 3 | 2007 | 6505 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2008 | 4874 | 0.040 |
Why?
| | Health Status | 1 | 2004 | 747 | 0.040 |
Why?
| | Critical Care | 1 | 2004 | 551 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2000 | 558 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 881 | 0.040 |
Why?
| | Physicians, Family | 1 | 2000 | 203 | 0.040 |
Why?
| | Poverty | 1 | 2022 | 497 | 0.040 |
Why?
| | Mental Health | 1 | 2004 | 683 | 0.040 |
Why?
| | Cohort Studies | 1 | 2008 | 5402 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3051 | 0.030 |
Why?
| | Research Design | 1 | 2022 | 1036 | 0.030 |
Why?
| | Prospective Studies | 1 | 2007 | 7069 | 0.030 |
Why?
| | Models, Educational | 1 | 2015 | 86 | 0.030 |
Why?
| | Capacity Building | 1 | 2015 | 58 | 0.030 |
Why?
| | Data Collection | 2 | 2009 | 649 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 185 | 0.030 |
Why?
| | Research Support as Topic | 1 | 2015 | 111 | 0.030 |
Why?
| | Inflammation | 2 | 2004 | 2666 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 5740 | 0.030 |
Why?
| | Histamine | 1 | 1991 | 65 | 0.020 |
Why?
| | Art | 1 | 2010 | 8 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 14471 | 0.020 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1991 | 126 | 0.020 |
Why?
| | Public Policy | 1 | 2010 | 67 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 2008 | 2710 | 0.020 |
Why?
| | Psychology | 1 | 2010 | 81 | 0.020 |
Why?
| | Risk Management | 1 | 2010 | 85 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1991 | 148 | 0.020 |
Why?
| | Ethanolamines | 1 | 1989 | 17 | 0.020 |
Why?
| | Adrenergic Agonists | 1 | 2008 | 5 | 0.020 |
Why?
| | Forced Expiratory Volume | 4 | 1992 | 511 | 0.020 |
Why?
| | Social Behavior | 1 | 2011 | 288 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1991 | 304 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 301 | 0.020 |
Why?
| | Self Administration | 1 | 2008 | 122 | 0.020 |
Why?
| | Morale | 1 | 2007 | 5 | 0.020 |
Why?
| | Perception | 1 | 2010 | 336 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 335 | 0.020 |
Why?
| | Career Choice | 1 | 2009 | 207 | 0.020 |
Why?
| | Insurance, Health | 1 | 2009 | 267 | 0.020 |
Why?
| | Quality Improvement | 1 | 2015 | 1097 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1164 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2263 | 0.020 |
Why?
| | Forms and Records Control | 1 | 2006 | 22 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 965 | 0.020 |
Why?
| | Education | 1 | 2006 | 100 | 0.020 |
Why?
| | Emotions | 1 | 2010 | 535 | 0.010 |
Why?
| | Teaching | 1 | 2007 | 210 | 0.010 |
Why?
| | Age Distribution | 1 | 2006 | 373 | 0.010 |
Why?
| | Sex Distribution | 1 | 2006 | 358 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 518 | 0.010 |
Why?
| | Double-Blind Method | 2 | 2006 | 1856 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1817 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2009 | 604 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 712 | 0.010 |
Why?
| | Oxygen | 1 | 2009 | 901 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2008 | 573 | 0.010 |
Why?
| | Databases, Factual | 1 | 2009 | 1267 | 0.010 |
Why?
| | Patient Selection | 1 | 2007 | 661 | 0.010 |
Why?
| | Pharmacies | 1 | 2004 | 36 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2007 | 396 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1358 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2008 | 728 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2004 | 245 | 0.010 |
Why?
| | Peak Expiratory Flow Rate | 2 | 1992 | 36 | 0.010 |
Why?
| | Methacholine Chloride | 2 | 1992 | 51 | 0.010 |
Why?
| | Bronchial Provocation Tests | 2 | 1992 | 50 | 0.010 |
Why?
| | Patient Readmission | 1 | 2006 | 665 | 0.010 |
Why?
| | Lung | 1 | 1992 | 3748 | 0.010 |
Why?
| | Health Behavior | 1 | 2005 | 740 | 0.010 |
Why?
| | Sleep Stages | 2 | 1989 | 45 | 0.010 |
Why?
| | Communication | 1 | 2005 | 841 | 0.010 |
Why?
| | Random Allocation | 2 | 1989 | 344 | 0.010 |
Why?
| | Delayed-Action Preparations | 2 | 1989 | 170 | 0.010 |
Why?
| | Sleep | 2 | 1991 | 682 | 0.010 |
Why?
| | Pindolol | 1 | 1991 | 15 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1991 | 47 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1991 | 32 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1991 | 204 | 0.010 |
Why?
| | Isoproterenol | 1 | 1991 | 112 | 0.010 |
Why?
| | Cell Count | 1 | 1991 | 310 | 0.010 |
Why?
| | Methacholine Compounds | 1 | 1990 | 2 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1991 | 326 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1991 | 231 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1991 | 208 | 0.010 |
Why?
| | Cell Separation | 1 | 1991 | 312 | 0.010 |
Why?
| | Leukocytes | 1 | 1991 | 303 | 0.000 |
Why?
| | Sodium Chloride | 1 | 1990 | 138 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1989 | 80 | 0.000 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1991 | 488 | 0.000 |
Why?
| | Pulmonary Gas Exchange | 1 | 1989 | 118 | 0.000 |
Why?
| | Bronchi | 1 | 1990 | 241 | 0.000 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1991 | 624 | 0.000 |
Why?
| | Administration, Oral | 1 | 1989 | 767 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1989 | 1951 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1989 | 1003 | 0.000 |
Why?
|
|
Cicutto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|